Efficacy of Zinc in the Treatment of Pneumonia

Efficacy of Zinc in the Treatment of Pneumonia in Hospitalized Children Less Than 2 Years of Age

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00198666

Enrollment

299

Registered

2005-09-20

Start date

2003-09-30

Completion date

2004-08-31

Last updated

2015-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia

Keywords

Pneumonia, zinc

Brief summary

This study is designed to evaluate the efficacy of zinc supplementation in the treatment of children under the age of two years who have been hospitalized with severe pneumonia.

Detailed description

This study was a randomized, double-blind, placebo-controlled clinical trial conducted between September 2003 and August 2004 at the Christian Medical College (CMC) Hospital in Vellore, India. CMC Hospital is a large teaching hospital and medical center that is accessed directly by the population of Vellore and adjoining districts and by referrals from local medical practitioners.

Interventions

DRUGZinc

Elemental Zinc

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Investigator)

Eligibility

Sex/Gender

ALL

Age

No minimum to 23 Months

Healthy volunteers

Inclusion criteria

* children under two years old hospitalized with Pneumonia

Exclusion criteria

* healthy children

Design outcomes

Primary

Measure	Time frame
Duration of severe symptoms	2 years

Secondary

Measure	Time frame
Time to recovery from severe pneumonia	2 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 7, 2026